Indication

OXERVATE (cenegermin-bkbj) ophthalmic solution 0.002% (20 mcg/mL) is indicated for the treatment of neurotrophic keratitis.

Register Now for an OXERVATE^® Promotional Program Near You

Join your peers to learn more about identification and diagnosis of neurotrophic keratitis and treatment with OXERVATE.

Indication

OXERVATE (cenegermin-bkbj) ophthalmic solution 0.002% (20 mcg/mL) is indicated for the treatment of neurotrophic keratitis.

Upcoming Programs

The OXERVATE Experience

Learn more about identification and diagnosis of neurotrophic keratitis and the clinical profile of OXERVATE for the treatment of NK.

The OXERVATE Experience

Date

January 29, 2026 6:30 PM Eastern Standard Time

Presented By

Jai Parekh

Location
The Capital Grille
1 Garden State Plaza Blvd
Paramus, NJ 07652

The OXERVATE Experience

Date

February 03, 2026 6:30 PM Eastern Standard Time

Presented By

Jai Parekh

Location
The Highlawn
1 Crest Dr
West Orange, NJ 07052

The OXERVATE Experience

Date

February 05, 2026 6:30 PM Eastern Standard Time

Presented By

Richard Najac

Location
Pescada New York
1359 Coney Island Avenue
Brooklyn, NY 11230

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Contact Lens, either therapeutic or corrective, should be removed before applying OXERVATE. Contact lenses may be reinserted 15 minutes after OXERVATE administration.

Eye Discomfort, such as eye pain, that can be mild to moderate can occur with OXERVATE. Patients should contact their health care provider if a more serious eye reaction occurs.

ADVERSE REACTIONS

The most common adverse reaction with OXERVATE (~16%) was eye pain. Other adverse reactions with OXERVATE (1% to 10%) included corneal deposits, foreign body sensation, ocular hyperemia, ocular inflammation, photophobia, tearing, and headache

Please see full Prescribing Information for OXERVATE.

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Contact Lens, either therapeutic or corrective, should be removed before applying OXERVATE. Contact lenses may be reinserted 15 minutes after OXERVATE administration.

Indication

Register Now for an OXERVATE® Promotional Program Near You

Join your peers to learn more about identification and diagnosis of neurotrophic keratitis and treatment with OXERVATE.

Indication

Upcoming Programs

The OXERVATE Experience

The OXERVATE Experience

The OXERVATE Experience

The OXERVATE Experience

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

ADVERSE REACTIONS

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

ADVERSE REACTIONS

Register Now for an OXERVATE^® Promotional Program Near You